The rise of dental spas, offering both dental care and injections of Botox, Juvéderm, and Restylane, for purely aesthetic, cosmetic purposes unrelated to any dental treatment or care, presents a complex legal landscape that...more
6/25/2024
/ Botox ,
Business Entities ,
Cosmetic Surgery ,
Cosmetics ,
Dental Practice ,
Dentists ,
Health Care Providers ,
Pharmaceutical Industry ,
Regulatory Standards ,
Standard of Care ,
State and Local Government
The Federal No Surprises Act (“NSA”) was signed into law on December 27, 2020, as part of the Consolidated Appropriations Act of 2021. Since its enactment, the NSA has been supplemented on two occasions by regulations which...more